Inhibition of Breast and Ovarian Tumor Growth through Multiple Signaling Pathways by Using Retrovirus-mediated Small Interfering RNA against Her-2/neu Gene Expression-Reference-Cited by-同舟云学术

Inhibition of Breast and Ovarian Tumor Growth through Multiple Signaling Pathways by Using Retrovirus-mediated Small Interfering RNA against Her-2/neu Gene Expression

Published:2004-02 Issue:6 Volume:279 Page:4339-4345
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Yang Gong,Cai Kathy Qi,Thompson-Lanza Jennifer A.,Bast Robert C.,Liu Jinsong

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference47 articles.

2. The neu oncogene encodes an epidermal growth factor receptor-related protein

3. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

4. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.

5. Specificity within the EGF family/ErbB receptor family signaling network

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer;International Journal of Clinical Oncology;2024-02-27

2. Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer;Chemical Biology & Drug Design;2022-09-25

3. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis;Antioxidants;2022-06-17

4. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies;Medical Oncology;2021-07-16

5. Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives;Journal of Medicinal Chemistry;2020-11-23